Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GRC-17536 is an orally available, potent, and selective transient receptor potential anchor protein 1 (TRPA1) inhibitor that has been shown to be highly effective in the treatment of inflammation and neuropathic pain in animal models. The selectivity of GRC-17536 is more than 1000 times higher than that of other TRPs, numerous GPCRs, enzymes, and other ion channels.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | GRC-17536 is an orally available, potent, and selective transient receptor potential anchor protein 1 (TRPA1) inhibitor that has been shown to be highly effective in the treatment of inflammation and neuropathic pain in animal models. The selectivity of GRC-17536 is more than 1000 times higher than that of other TRPs, numerous GPCRs, enzymes, and other ion channels. |
Synonyms | GRC17536, GRC 17536 |
Molecular Weight | 555.56 |
Formula | C20H13F5KN4O3S2 |
CAS No. | 1649479-05-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GRC-17536 1649479-05-9 GRC17536 GRC 17536 inhibitor inhibit